11/15/2024
4:02 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
5:03 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/14/2024
5:21 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/12/2024
4:08 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
9:05 AM | Calidi Biotherapeutics (Subject)
NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
10/24/2024
4:18 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
8:38 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
|
10/23/2024
7:25 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
10/18/2024
4:25 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
4:29 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
4:05 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
09/30/2024
5:53 PM | Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
8:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
5:10 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:12 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
3:04 PM | Calidi Biotherapeutics (Subject)
Funicular Funds, LP (Filed by)
| Form SC 13G | |
08/22/2024
4:16 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
5:04 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
4:10 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
8:15 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
3:58 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
3:51 PM | Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2024
3:53 PM | Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
7:20 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:22 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:12 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:14 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:16 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:18 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:15 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Jackson Andrew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Campbell Wendy Pizarro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Minev Boris Radoslavov (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
06/05/2024
3:15 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
4:24 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
05/17/2024
3:35 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:24 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
05/14/2024
8:01 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:57 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:00 PM | Calidi Biotherapeutics (Filer)
| Form DEF 14A | |
05/01/2024
11:57 AM | Calidi Biotherapeutics (Subject)
Kessler Judd S (Filed by)
| Form SCHEDULE 13D | |
04/19/2024
4:25 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
4:20 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
4:00 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
3:15 PM | Calidi Biotherapeutics (Filer)
| Form 424B4 | |
04/16/2024
11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
04/15/2024
5:31 AM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
04/08/2024
3:40 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
04/02/2024
4:29 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
04/01/2024
8:00 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
8:47 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
03/18/2024
7:41 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
4:28 PM | Calidi Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/12/2024
7:00 PM | Calidi Biotherapeutics (Issuer)
LaPre David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2024
4:28 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
03/12/2024
3:51 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:24 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:27 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
02/14/2024
5:05 AM | Calidi Biotherapeutics (Subject)
First Light Acquisition Group, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
4:32 PM | Calidi Biotherapeutics (Subject)
First Trust Capital Management L.P. (Filed by)
| Form SC 13G/A | |
02/12/2024
5:30 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
5:32 AM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
02/09/2024
4:03 PM | Calidi Biotherapeutics (Subject)
SPRING CREEK CAPITAL LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
5:53 AM | Calidi Biotherapeutics (Subject)
Polar Asset Management Partners Inc. (Filed by)
| Form SC 13G/A | |
02/07/2024
12:06 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
11:35 AM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
02/01/2024
4:00 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
4:10 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
01/29/2024
8:32 AM | Calidi Biotherapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/21/2024
11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
01/16/2024
5:31 AM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
01/08/2024
7:00 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
5:31 AM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
01/05/2024
7:00 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:55 PM | Calidi Biotherapeutics (Issuer)
Zulueta Alfonso G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:49 PM | Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:49 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:51 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:52 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
6:52 PM | Calidi Biotherapeutics (Issuer)
Vecchiolla Thomas A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:00 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
4:17 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
4:24 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
